Clinical Trials at Carolina Urologic Research Center
As of August 2026, 30 paid clinical trials are recruiting at Carolina Urologic Research Center in Myrtle Beach, South Carolina. Active studies at this site cover conditions such as Prostate Cancer, Metastatic Castration-resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
30 clinical trials at Carolina Urologic Research Center
·Clear filters·A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
A Study of GEN1106 in Participants With Solid Tumors
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Common conditions studied in Myrtle Beach
- Prostate Cancer (11 active studies)
- Metastatic Castration-resistant Prostate Cancer (5 active studies)
- Metastatic Castration-Resistant Prostate Cancer (4 active studies)
- Non-muscle Invasive Bladder Cancer (3 active studies)
- Non-muscle Invasive Bladder Cancer With Carcinoma in Situ (3 active studies)
- Prostate Cancer (Adenocarcinoma) (3 active studies)
Leading research sponsors in Myrtle Beach
- AstraZeneca
- Pfizer
- Janssen Research & Development, LLC
- Novartis Pharmaceuticals
- Amgen
Frequently asked questions
How many paid clinical trials are currently recruiting in Myrtle Beach?
There are approximately 74 recruiting clinical trials in Myrtle Beach, South Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Myrtle Beach pay participants?
Most recruiting trials in Myrtle Beach compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Myrtle Beach?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Myrtle Beach?
The most common conditions under active study in Myrtle Beach include Prostate Cancer (11), Metastatic Castration-resistant Prostate Cancer (5), Metastatic Castration-Resistant Prostate Cancer (4), Non-muscle Invasive Bladder Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Myrtle Beach?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Myrtle Beach on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Myrtle Beach?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Myrtle Beach?
Recruiting research sites in Myrtle Beach include Carolina Urologic Research Center, Carolina Urologic Research Center, LLC, Parkway Surgery Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Myrtle Beach right now?
The largest active categories in Myrtle Beach are Cancer & tumors (55), Diabetes & metabolic (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.